| Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis G Caridi, R Bertelli, A Carrea, M Di Duca, P Catarsi, M Artero, M Carraro, ... Journal of the American Society of Nephrology 12 (12), 2742-2746, 2001 | 252 | 2001 |
| Polymorphisms in the osteopontin promoter affect its transcriptional activity F Giacopelli, R Marciano, A Pistorio, P Catarsi, S Canini, G Karsenty, ... Physiological genomics 20 (1), 87-96, 2004 | 164 | 2004 |
| Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation V Rosti, L Villani, R Riboni, V Poletto, E Bonetti, L Tozzi, G Bergamaschi, ... Blood, The Journal of the American Society of Hematology 121 (2), 360-368, 2013 | 125 | 2013 |
| Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis G Barosi, V Rosti, E Bonetti, R Campanelli, A Carolei, P Catarsi, AM Isgro, ... PloS one 7 (4), e35631, 2012 | 114 | 2012 |
| Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study GM Ghiggeri, P Catarsi, F Scolari, G Caridi, R Bertelli, A Carrea, ... Clinical therapeutics 26 (9), 1411-1418, 2004 | 78 | 2004 |
| Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives A Magnasco, A Rossi, P Catarsi, R Gusmano, F Ginevri, F Perfumo, ... Current Clinical Pharmacology 3 (3), 166-173, 2008 | 76 | 2008 |
| Acetylcholine induces intracellular Ca2+ oscillations and nitric oxide release in mouse brain endothelial cells E Zuccolo, D Lim, DA Kheder, A Perna, P Catarsi, L Botta, V Rosti, ... Cell Calcium 66, 33-47, 2017 | 72 | 2017 |
| Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin D Marimpietri, B Nico, A Vacca, D Mangieri, P Catarsi, M Ponzoni, ... Oncogene 24 (45), 6785-6795, 2005 | 72 | 2005 |
| Conjugated polymers optically regulate the fate of endothelial colony-forming cells F Lodola, V Rosti, G Tullii, A Desii, L Tapella, P Catarsi, D Lim, F Moccia, ... Science advances 5 (9), eaav4620, 2019 | 63 | 2019 |
| Arachidonic acid-evoked Ca2+ signals promote nitric oxide release and proliferation in human endothelial colony forming cells E Zuccolo, S Dragoni, V Poletto, P Catarsi, D Guido, A Rappa, ... Vascular Pharmacology 87, 159-171, 2016 | 62 | 2016 |
| JAK2V617F allele burden⩾ 50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy G Barosi, C Klersy, L Villani, E Bonetti, P Catarsi, V Poletto, R Campanelli, ... Leukemia 30 (8), 1772-1775, 2016 | 54 | 2016 |
| A3669G polymorphism of glucocorticoid receptor is a susceptibility allele for primary myelofibrosis and contributes to phenotypic diversity and blast transformation V Poletto, V Rosti, L Villani, P Catarsi, A Carolei, R Campanelli, M Massa, ... Blood, The Journal of the American Society of Hematology 120 (15), 3112-3117, 2012 | 41 | 2012 |
| Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis M Bruschi, P Catarsi, G Candiano, MP Rastaldi, L Musante, F Scolari, ... Kidney international 63 (2), 686-695, 2003 | 37 | 2003 |
| Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive … G Barosi, M Massa, R Campanelli, G Fois, P Catarsi, G Viarengo, L Villani, ... Leukemia research 60, 18-23, 2017 | 36 | 2017 |
| Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis S Badalucco, CA Di Buduo, R Campanelli, I Pallotta, P Catarsi, V Rosti, ... Haematologica 98 (4), 514, 2013 | 34 | 2013 |
| Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms MA Avanzini, ME Bernardo, F Novara, M Mantelli, V Poletto, L Villani, ... Leukemia 28 (8), 1742-1745, 2014 | 32 | 2014 |
| Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells. V Abbonante, C Gruppi, P Catarsi, MA Avanzini, ME Tira, G Barosi, ... British Journal of Haematology 172 (1), 2016 | 22 | 2016 |
| JAK2 V617F Genotype Is a Strong Determinant of Blast Transformation in Primary Myelofibrosis G Barosi, V Poletto, M Massa, R Campanelli, L Villani, E Bonetti, ... PLoS One 8 (3), e59791, 2013 | 21 | 2013 |
| JAK2 46/1 haplotype predisposes tosplanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferativeneoplasms. L Villani, G Bergamaschi, M Primignani, V Rosti, A Carolei, V Poletto, ... Leukemia Research 36, 7-9, 2012 | 21 | 2012 |
| Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis M Massa, R Campanelli, G Fois, L Villani, E Bonetti, P Catarsi, V Poletto, ... Blood, The Journal of the American Society of Hematology 128 (12), 1660-1662, 2016 | 18 | 2016 |
